Importantly, wild-type p53 can cooperate with p73 to enforce tumour-suppressive pathways, whereas mutant p53 exerts dominant-negative effects by binding and functionally inactivating p73 [12,14,15]. The gene discussed is TP73; the disease is neoplasm.